$JNJ Company News Why you should favor large-cap stocks

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 11:55 AM

$JNJ Company News

Why you should favor large-cap stocks for the next six weeks 5:50 a.m. Today - Mark Hulbert
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Republican victory will boost these 21 stocks 7:45 a.m. Nov. 5, 2014 - Michael Brush
Ebola play Halyard Health stock gains are modest 1:02 p.m. Nov. 3, 2014 - Russ Britt
Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore

Stock Market Today: Stocks Fluctuate as Fed Rate Hike Worries Trump Retail Sales 18 min ago - TheStreet.com
What Licensing Imetelstat Will Mean for Geron 10:45 a.m. Today - 247WallSt.com
Setting Up A Portfolio That Millennials Can Relate To 10:05 a.m. Today - Seeking Alpha
The Post AASLD Annual Meeting Hepatitis C Landscape 6:15 a.m. Today - Seeking Alpha
Geron wins deal to develop blood disorder drug, could get $935M 5:55 p.m. Nov. 13, 2014 - Seeking Alpha
AstraZeneca/Amgen's Brodalumab Positive in Psoriasis Trial - Analyst Blog 5:10 p.m. Nov. 13, 2014 - Zacks.com
Geron Licenses Experimental Myelofibrosis Drug to Johnson & Johnson 4:34 p.m. Nov. 13, 2014 - TheStreet.com
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
Total Return And Dividend Growth Investing 3:50 p.m. Nov. 13, 2014 - Seeking Alpha
Mallinckrodt Says FDA Reclassified ADHD Generic Drug 1:21 p.m. Nov. 13, 2014 - The Wall Street Journal Interactive Edition
Does The End Of QE Portend A New Beginning For Income Investors? 12:48 p.m. Nov. 13, 2014 - Seeking Alpha
Tracking Tweedy Browne Portfolio - Q3 2014 Update 11:14 a.m. Nov. 13, 2014 - Seeking Alpha
FDA clears label expansion for Janssen antipsychotic 10:53 a.m. Nov. 13, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: JPM, JNJ, PG 10:29 a.m. Nov. 13, 2014 - TheStreet.com
Mallinckrodt ADHD Drug Hits FDA Trouble; Stock Drops 10:09 a.m. Nov. 13, 2014 - Investors Business Daily
FDA downgrades classification of Mallinckrodt's ADHD med 7:33 a.m. Nov. 13, 2014 - Seeking Alpha
Successful Dividend Investing Requires Patience 2:48 a.m. Nov. 13, 2014 - Seeking Alpha
Margin Of Safety: More Than Just Price 12:34 a.m. Nov. 13, 2014 - Seeking Alpha
The Problem With "Just Exchanging Your Shares" 12:25 a.m. Nov. 13, 2014 - Seeking Alpha
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog 5:00 p.m. Nov. 12, 2014 - Zacks.com

Nicholas Valeriani Appointed To Edwards Lifesciences' Board Of Directors 9:00 a.m. Today - PR Newswire - PRF
Amcor Rigid Plastics Renews National Sponsorshipof America Recycles Day 2014 7:29 p.m. Nov. 11, 2014 - BusinessWire - BZX
La Lumiere Closes $20 Million Series B Financing 8:02 a.m. Nov. 11, 2014 - PR Newswire - PRF
CORRECTING and REPLACING Biosense Webster Teams Up with StopAfib.org to Challenge Americans to Get SMART About AfibSM 7:40 p.m. Nov. 10, 2014 - BusinessWire - BZX
VYCOR: "On the Cusp of the Next Big Healthcare Trend" 9:23 a.m. Nov. 10, 2014 - ACCESSWIRE
HackerAgency Names New Director of Strategic Planning; Adds Senior Client Leadership 8:35 a.m. Nov. 10, 2014 - PR Newswire - PRF
Biosense Webster Teams Up with StopAfib.org to Challenge Americans to Get SMART About AfibSM 8:03 a.m. Nov. 10, 2014 - BusinessWire - BZX
New President and New Offices Signal New Era for New Jersey-based BNO 6:36 p.m. Nov. 7, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Completion Of Alios BioPharma Acquisition 4:05 p.m. Nov. 7, 2014 - PR Newswire - PRF
Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA 8:50 a.m. Nov. 7, 2014 - PR Newswire - PRF
Alios BioPharma to Present Preclinical Data on Its Anti-HCV Nucleotides AL-335 and AL-516 at the 2014 American Association for the Study of Liver Diseases Annual Meeting 4:20 p.m. Nov. 6, 2014 - Marketwired
DECN's Subsidiary Initiates First in Industry Social Media Marketing Campaign for Genstrip50 9:26 a.m. Nov. 5, 2014 - ACCESSWIRE
Baron and Budd Investigating Potential Xarelto Lawsuits 4:03 p.m. Nov. 4, 2014 - BusinessWire - BZX
Legal-Bay Lawsuit Settlement Funding Updates News on All Major Hip Litigations 5:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019 8:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
In 2023, Medivation/Astellas Pharma's Xtandi Will Be the Top-Selling Agent in the Prostate Cancer Market Across the United States, Europe, and Japan 1:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for Technology Translation (JITT) As Founding Members 9:00 a.m. Oct. 30, 2014 - BusinessWire - BZX
Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation 5:15 a.m. Oct. 29, 2014 - Thomson Reuters ONE
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Investor Impact Deep Dive

What's Going On with Webull? Ah, Webull Corporation, you're in the hot seat now. If you blinked on October 7th, you might have missed a monumental 19.09% cliff dive in Webull's stock, tumbling down to a humble $5.89. The roar wasn't just the market reacting; it was the sonic boom of a class action lawsuit on their heels, alleging some slick legal sledding with misleading...

Junior Golf Stars Shine at Notah Begay III Championship

Ever wonder where the golf stars of tomorrow get their start? Well, you might find a few of 'em teeing off at the Notah Begay III Junior Golf National Championship. This year, the spotlight is shining on the fairways of the Coushatta Resort in Louisiana. And let me tell you, the talent pool is something to behold. Young golfers from across the globe are swinging their way...

Marc Ryan Joins ABCS Insights as Chief Product Officer

Shaping the Future of Advertising Effectiveness In the ever-evolving ad measurement arena, where understanding what works can make or break a company, ABCS Insights has tossed a game-changing hat into the ring. They've just announced Marc Ryan as their new Chief Product Officer. Now, I’ve seen seasoned execs shuffle seats countless times, but this one’s...

ATTACK SHARK's X60: A New Era in Gaming Audio

Gaming Audio Gets a Power Boost with X60 We're diving headfirst into an era where gaming headsets promise more bells and whistles than ever before. This isn't just some random gadget plopped on the market. ATTACK SHARK's X60 Gaming Headset is strutting in, guns blazing, ready to take on the heavyweights in the competitive gaming world. It's not just about being another...

Cyclists and Trains: A New Chapter in Urban Travel

Rolling Without Engines: LA to SD Picture this: over 75 cyclists and their compact, foldable steeds embarking on a train journey from Los Angeles to the sun-drenched streets of San Diego. In an era where travel is often synonymous with congestion and pollution, this collaboration between Amtrak's Pacific Surfliner and Brompton Bicycle was like a breath of fresh sea air....

Tiny Fish Revolutionizes Vertebrate Gene Studies

From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...

Service Pros Adds Windshield Repair to Lineup

Revving Up the Service Engine Alright, folks, buckle up because Service Pros Auto Glass, our local go-to for windshield replacements, is cranking up their game. They're stepping into the windshield repair arena across Florida and South Carolina, aiming to save you a buck and keep you safe behind the wheel. That's a double win if you ask me. A Closer Look at the Details...

Navigating Homeowner Deductibles: Balancing Costs

Understanding the Basics: Premiums and Deductibles Picture sorting through bills with a cup of lukewarm coffee, wondering if there’s a smarter way to handle homeowner insurance. Chuck Montgomery cuts through the fluff, talking turkey about balancing insurance dollars. One part of the game is deciding your deductible, the sum you fork over before insurance steps in...

Palmetto Publishing's M&A Guide Aims to Boost Home Services

Palmetto's New Release: Mergers & Acquisitions Focus Man, Palmetto Publishing just dropped a bombshell for home services aficionados with their latest M&A guide. Now, if you’re like me, swimming in stocks and always looking for that next big exit play, this one’s tailor-made for you. Mergers and acquisitions might not sound as flashy as the tech darlings or...

Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...